ResMed Inc.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various …
Medical - Instruments & Supplies
US, San Diego [HQ]
Financials
Analysts
Wall Street · Earnings · Institutional SentimentA comprehensive analysis section that covers unveiling insights about ResMed Inc.'s gradings, price targets and earnings estimates.
Earnings
See the historical earnings and what wall street
analysts forecasted and
forecast for
future earnings.
Reported
Past Estimate Consensus
Future Estimate Consensus
| FY | EPS | Revenue [mil.] | Profit [mil.] | EBITDA [mil.] | EBIT [mil.] | Expenses · SGA [mil.] | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E | E | E | E | E | E | |||||||
| 2014 | 2.4400 | 2.340 | 1,554 | 1,520 | 345 | 321 | 427 | 477 | 411 | 379 | 450 | 431 |
| 2015 | 2.5100 | 2.385 | 1,678 | 1,663 | 352 | 345 | 494 | 502 | 415 | 399 | 472 | 462 |
| 2016 | 2.5100 | 2.654 | 1,838 | 1,826 | 352 | 343 | 540 | 499 | 441 | 405 | 482 | 467 |
| 2017 | 2.4200 | 2.787 | 2,066 | 2,071 | 342 | 333 | 599 | 516 | 456 | 412 | 553 | 524 |
| 2018 | 2.2100 | 3.487 | 2,340 | 2,344 | 315 | 279 | 698 | 556 | 560 | 448 | 600 | 534 |
| 2019 | 2.8300 | 3.606 | 2,606 | 2,602 | 404 | 432 | 843 | 679 | 635 | 561 | 645 | 589 |
| 2020 | 4.3100 | 4.508 | 2,957 | 2,943 | 621 | 411 | 989 | 714 | 809 | 589 | 676 | 621 |
| 2021 | 3.2700 | 5.295 | 3,196 | 3,119 | 474 | 559 | 1,112 | 840 | 912 | 702 | 670 | 532 |
| 2022 | 5.3400 | 5.711 | 3,578 | 3,576 | 779 | 492 | 1,194 | 1,101 | 1,000 | 930 | 739 | 672 |
| 2023 | 6.1200 | 6.505 | 4,222 | 4,238 | 897 | 620 | 1,339 | 1,220 | 1,151 | 789 | 874 | 578 |
| 2024 | - | 7.727 | - | 4,679 | - | 1,112 | - | 1,342 | - | 868 | - | 636 |
| 2025 | - | 9.387 | - | 5,117 | - | 1,327 | - | 1,714 | - | 1,440 | - | 1,072 |
| 2026 | - | 10.355 | - | 5,495 | - | 3.F12X/td> | - | 3.F121/td> | - | 3.F121 | - | 3.F121 |
| 2027 | - | 11.320 | - | 5,895 | - | 2.F13X/td> | - | 2.F131/td> | - | 2.F131 | - | 2.F131 |
| 2028 | - | 11.981 | - | 6,259 | - | 1.F14X/td> | - | 1.F141/td> | - | 1.F141 | - | 1.F141 |
| 2029 | - | 13.165 | - | 6,834 | - | 0.F15X/td> | - | 0.F151/td> | - | 0.F151 | - | 0.F151 |
Institutional Sentiment
Wall Street · Earnings · Institutional Sentiment
Morgan Stanley
1Y Ago:
n/a
Prev. Grade
n/a
Latest
n/a
JP Morgan Chase
1Y Ago:
Overweight
Prev. Grade
Overweight
Dec. 12, 2024
Overweight
Citigroup
1Y Ago:
Equal-Weight
Prev. Grade
Underweight
Dec. 12, 2024
Equal-Weight
Overall Consensus
Grading Consensus
Click to each, to see the gradePrice Target Consensus
-5.239% $12.43 · MISS
Nov. 6, 2024Price Then
$245.74
Price Target
$249.70
Price Now
$237.27